Pancreatic alpha cell mass in European subjects with type 2 diabetes

[1]  L. Orci,et al.  Paracrinology of islets and the paracrinopathy of diabetes , 2010, Proceedings of the National Academy of Sciences.

[2]  T. Berney,et al.  Unique Arrangement of α- and β-Cells in Human Islets of Langerhans , 2010, Diabetes.

[3]  D. Steiner,et al.  No mantle formation in rodent islets -- the prototype of islet revisited. , 2009, Diabetes research and clinical practice.

[4]  S. Kahn,et al.  The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality , 2009, Diabetologia.

[5]  C. Sempoux,et al.  Pancreatic β‐cell mass in European subjects with type 2 diabetes , 2008, Diabetes, obesity & metabolism.

[6]  I. Quesada,et al.  REVIEW Physiology of the pancreatic a -cell and glucagon secretion: role in glucose homeostasis and diabetes , 2008 .

[7]  J. Gerich,et al.  The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. , 2007, Endocrine reviews.

[8]  P. Pour,et al.  Distribution of Pancreatic Endocrine Cells Including IAPP-expressing Cells in Non-diabetic and Type 2 Diabetic Cases , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  Camillo Ricordi,et al.  The unique cytoarchitecture of human pancreatic islets has implications for islet cell function , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Alvin C. Powers,et al.  Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[11]  B. Wolf,et al.  Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. , 2004, Diabetes.

[12]  E. Cerasi.  Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible? , 1995, Diabetologia.

[13]  R. Goebbels,et al.  Cellular composition of the human diabetic pancreas , 1983, Diabetologia.

[14]  Jae-Hyoung Cho,et al.  Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea , 2003 .

[15]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[16]  S. Yagihashi,et al.  Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients , 2002, Diabetologia.

[17]  D. Pipeleers,et al.  Differences in Glucose Transporter Gene Expression between Rat Pancreatic α- and β-Cells Are Correlated to Differences in Glucose Transport but Not in Glucose Utilization (*) , 1995, The Journal of Biological Chemistry.

[18]  R. Holman,et al.  Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. , 1988, Diabetes research.

[19]  M. Löhr,et al.  Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. , 1985, Survey and synthesis of pathology research.

[20]  L. Orci,et al.  Quantitation of Endocrine Cell Content in the Pancreas of Nondiabetic and Diabetic Humans , 1982, Diabetes.

[21]  G WhittakerP,et al.  共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値 , 1980 .

[22]  Tohru Takahashi,et al.  Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. , 1979, The Tohoku journal of experimental medicine.

[23]  L. Orci,et al.  THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUS , 1975, The Lancet.

[24]  W. Gepts.  [Histopathological changes of the islands of Langerhans and their importance in the problem of the pathogenesis of human diabetes]. , 1958, Endokrinologie.

[25]  R. Ogilvie,et al.  Quantitative Estimation of the Pancreatic Islet Tissue in Diabetic Subjects , 1955, Diabetes.

[26]  H. W. Chalkley.  Method for the Quantitative Morphologic Analysis of Tissues , 1943 .